The COVID -19 pandemic replaced face -to -face meetings with virtual ones. Yet the research and innovation have not stopped and new data are available for presentation, irrespective of the meeting format. In this article, we present a brief overview of the late -breaking clinical trials presented at the Transcatheter Valve Therapies (TVT) Connect 2020 conference, as well as selected structural clinical trials presented at the Paris Course of Revascularisation (PCR) e -Course 2020, that carry significant clinical implications.
